An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain.
This post first appeared in The New York Times – Business. Read the original article.How an Opioid Settlement Hinders Patients’ Access to ADHD Medication and Other Drugs
The New York Times – Business:
Written by
in
